Nymox Pharmaceutical Corp (NASDAQ:NYMX)

Monday’s Trading Day
1.62 +0.63 / +63.64%
As of Apr 20
Day’s Change
Tuesday’s Pre-Market   Switch to standard view »
1.77 +0.15 / +9.26%
 
Volume: --

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues691.5K3.1M3.1M3.4M
 
 
 
 
 
Cost of Goods Sold316.9K275.2K253.9K486.2K
 
 
 
 
 
Depreciation And Amortization10.2K14.7K10.4K9.1K
 
 
 
 
 
 
Operating ExpensesGross Income364.3K2.8M2.8M2.9M
 
 
 
 
 
General Expenses7.6M12.4M10.7M8.3M
 
 
 
 
 
Other Operating Expenses7.1K0.000.000.00
 
 
Research And Development4.8M9.0M8.6M6.3M
 
 
 
 
 
Total Operating Expenses7.9M12.7M11.0M8.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.2M-9.6M-7.9M-5.4M
 
 
 
 
 
Other Expenses0.00-39.9K-39.1K-27.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.2M-9.7M-7.9M-5.5M
 
 
 
 
 
Income Taxes-236.1K0.00-289.8K-555.0K
 
 
 
 
Net Income-7.0M-9.7M-7.6M-4.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS31.9M32.7M33.2M34.1M
 
 
 
 
 
Shares To Calculate EPS Diluted31.9M32.7M33.2M34.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.22-$0.30-$0.23-$0.14
 
 
 
 
 
EPS Diluted-$0.22-$0.30-$0.23-$0.14
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account